• About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
  • Eng
    • Рус
    • Укр
  • Eng
    • Рус
    • Укр
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
Головна » News

News

Category
Category Reset
Inscience Conference 2023
Growth

Inscience Conference 2023

We welcome Reka-Med to the YURіA-PHARM group of companies
Growth

We welcome Reka-Med to the YURіA-PHARM group of companies

Year of war in Ukraine
War in Ukraine

Year of war in Ukraine

YURiA-PHARM and Diaco teams attend CPI Worldwide 2021
Growth

YURiA-PHARM and Diaco teams attend CPI Worldwide 2021

We have good news: today we opened a YURіA-PHARM representative office in Moldova!
Growth

We have good news: today we opened a YURіA-PHARM representative office in Moldova!

YURіA-PHARM Group considers localising vaccine production in Ukraine
Growth

YURіA-PHARM Group considers localising vaccine production in Ukraine

YURIA-PHARM Group announces the completion of its 3-year ReoSTAT international clinical trial
Growth

YURIA-PHARM Group announces the completion of its 3-year ReoSTAT international clinical trial

Ukrainian drug in Canada!
Growth

Ukrainian drug in Canada!

“YURiA-PHARM” Corporation took part in the European Respiratory Society (ERS) International Congress
Growth

“YURiA-PHARM” Corporation took part in the European Respiratory Society (ERS) International Congress

  • 1
  • 2
This site uses cookies to give you a better browsing experience, you can find out more about the cookies we use here Confidentiality Policy
Accept

Sign for health professionals

If you are a health care professional, as a confirmation, press «ENTER» to get started.
Cancel
  • About the company
    • Who We Are
    • Philosophy
    • History
    • Managment
    • Sustainable Development
    • Reporting
  • Products
    • Product Catalog
    • Pharmacovigilance
    • Surveillance of Medical Devices
    • Library
  • R&D
    • R&D Hub
    • R&D Strategy
    • Therapeutic Focuses
    • Technologies
    • R&D Culture
    • Partnerships
    • Join the R&D Team
  • Career
    • About Us
    • Profi Day
    • Job Vacancies
    • Covid-19
  • For Partners
    • For Distributors
    • Partnerships
  • Media-Center
    • For Media
    • News
  • Contacts
  • Confidentiality Policy
Feedback
  • Product sites:
    • Instylan (EN, IT, ES, FR, PL)
    • Xavron (EN)
    • Tivortin (EN)
    • Ulaizer (EN)
    • Revul (EN)
Follow us

Contact form

    Delete
    Delete
    Delete
    Delete
    Delete